Details of the Drug Reposition

General Information of This Drug (ID: DMHLIQU)

Drug Name
ABBV-8E12   DMHLIQU
Synonyms C2N-8E12

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Progressive supranuclear palsy DISO5KRQ 8A00.10 Phase 2 [1]
Alzheimer disease DISF8S70 8A20 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02985879) A Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of ABBV-8E12 in Subjects With Progressive Supranuclear Palsy (PSP). U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT03712787) An Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD). U.S. National Institutes of Health.